Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia

Cancer

Volumn 78, Issue 3, 1996, Pages 471-479

  Myers, Ronald E ^a,c   Wolf, Thomas A ^a   McKee, Linda ^a   McGrory, Gene ^a   Burgh, Desiree Y ^a   Nelson, Gregory ^b   Nelson, Gail A ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Nelson Medical Group   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

adherence; African American; cancer; intention; prostate; screening

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ATTITUDE TO HEALTH; DATA COLLECTION; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS;

EID: 0029891094     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<471::AID-CNCR14>3.0.CO;2-W     Document Type: Article

References (33)

1. American Cancer Society. Cancer Facts & Figures - 1996. Atlanta: GA American Cancer Society, 1996:13-4.
2. Bales GT, Gerber GS. Screening for the early detection of carcinoma of the prostate. Prin Pract Oncol 1995;9:1-9.
3. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
4. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6.
5. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE. The Prostate Disease Patient Outcome Research Team. Arch Fam Med 1993;2:487-93.
6. Lirwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
7. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA 1994;272:773-80.
8. Health panel recommends less testing. The Wall Street Journal 1995 December 13;
9. Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin 1993;43:42-6.
10. Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer. United States. Cancer 1985;25:36-56.
11. Fincham SM, Hill GB, Hanson J, Wijaysinghe C. Epidemiology of prostatic cancer: a case-control study. Prostate 1990;17:189-206.
12. Steinberg GD, Carter BS, Beaty TH. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
13. National Cancer Institute. Cancer Statistics Review 1973-1988. Bethesda, MD: Government Printing Office, 1991.
14. Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 1995;46:771-7.
15. Slawin KM, Ohori M, Dillioglugil O, Scardino PT. Screening for prostate cancer: an analysis of the early experience. CA Cancer J Clin 1995;45:134-47.
16. Powell IJ. Early detection issues of prostate cancer in African American men. In Vivo 1994;8:451-2.
17. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health 1991;81:501-4.
18. Myers RE, Wolf TA, Balshem AM, Ross EA, Chodak GW. Receptivity of African-American men to prostate cancer screening. Urology 1994;43:480-7.
19. Rosenstock IM. The health belief model: explaining health behavior through expectancies. In: Glanz K, Lewis FM, Rimer B, (editors). Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass Publishers, 1991:39-62.
20. Ajzen I, Fishbein M. Understanding, attitudes and predicting social behavior, Englewood Cliffs, NJ: Prentice-Hall, 1980.
21. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall, 1986.
22. SAS Institute Inc. SAS software: changes and enhancements. Release 6.10. Cary, NC: SAS Institute Inc., 1994.
23. Hauck WW, Miike R. A proposal for examining and reporting stepwise regression. Stat Med 1991;10:711-5.
24. Millon-Underwood S, Sanders E. Factors contributing to health promotion behaviors among African-American men. Oncol Nurs Forum 1990;15:707-12.
25. Price JH, Colvin TL, Smith D. Prostate cancer perceptions of African-American males. J Natl Med Assoc 1993;85:941-7.
26. Berkman LF. Role of social relations in health promotion. Psychosom Med 1995;57:245-54.
27. Dimatteo MR, Hasy RD, Gritz ER, Bastani R, Crane L, Elashof R, Ganz P, Heber D, McCarthy W, Marcus A. Patient adherence to cancer control regimens: scale development and initial validation. Psychological Assessment 1993;5:102-12.
28. Gritz ER, Bastani R. Cancer prevention behavior changes: the short and the long of it. Preventive Medicine 1993;22:676-88.
29. Waldman AR, Osborne DM. Screening for prostate cancer. Oncol Nurs Forum 1994;21:1513-7.
30. Woolf SH. Screening for prostate cancer with prostate-specific antigen. N Engl J Med 1995;333:1401-5.
31. Barry MJ, Fowler FJ Jr., Aulley AG Jr., Henderson JV Jr., Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995;33:771-82.
32. Freeman HP, Jones WB. Access of the socioeconomically disadvantaged groups to cancer prevention and detection. Cancer 1988;61:2402-6.
33. Braithwaite RL, Lythcott N. Community empowerment as a strategy for health promotion for black and other minority populations. JAMA 1989;261:282-3.